286 related articles for article (PubMed ID: 8339260)
1. Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissues.
Albin N; Massaad L; Toussaint C; Mathieu MC; Morizet J; Parise O; Gouyette A; Chabot GG
Cancer Res; 1993 Aug; 53(15):3541-6. PubMed ID: 8339260
[TBL] [Abstract][Full Text] [Related]
2. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
3. Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systems.
Massaad L; de Waziers I; Ribrag V; Janot F; Beaune PH; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1992 Dec; 52(23):6567-75. PubMed ID: 1423302
[TBL] [Abstract][Full Text] [Related]
4. [Screening of principal enzymes involved in the metabolism of anticancer drugs in human and murine colonic tumors].
Massaad L; de Waziers I; Ribrag V; Janot F; Morizet J; Beaune PH; Gouyette A; Chabot GG
Bull Cancer; 1993 May; 80(5):397-407. PubMed ID: 8173193
[TBL] [Abstract][Full Text] [Related]
5. Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinoma.
Janot F; Massaad L; Ribrag V; de Waziers I; Beaune PH; Luboinski B; Parise O; Gouyette A; Chabot GG
Carcinogenesis; 1993 Jul; 14(7):1279-83. PubMed ID: 8330340
[TBL] [Abstract][Full Text] [Related]
6. Main drug-metabolizing enzyme systems in human non-Hodgkin's lymphomas sensitive or resistant to chemotherapy.
Ribrag V; Massaad L; Janot F; Morizet J; Gouyette A; Chabot GG
Leuk Lymphoma; 1995 Jul; 18(3-4):303-10. PubMed ID: 8535197
[TBL] [Abstract][Full Text] [Related]
7. Principal drug-metabolizing enzyme systems in L1210 leukemia sensitive or resistant to BCNU in vivo.
Ribrag V; Massaad L; Janot F; Bissery MC; Parise O; Gouyette A; Chabot GG
Leuk Res; 1994 Nov; 18(11):829-35. PubMed ID: 7967709
[TBL] [Abstract][Full Text] [Related]
8. Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38.
Massaad L; Chabot GG; Toussaint C; Koscielny S; Morizet J; Bissery MC; Gouyette A
Cancer Chemother Pharmacol; 1994; 34(6):497-502. PubMed ID: 7923560
[TBL] [Abstract][Full Text] [Related]
9. Glutathione transferase activity and isoenzyme composition in primary human breast cancers.
Shea TC; Claflin G; Comstock KE; Sanderson BJ; Burstein NA; Keenan EJ; Mannervik B; Henner WD
Cancer Res; 1990 Nov; 50(21):6848-53. PubMed ID: 2208151
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
11. The immunohistochemical localization of drug-metabolizing enzymes in prostate cancer.
Murray GI; Taylor VE; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD
J Pathol; 1995 Oct; 177(2):147-52. PubMed ID: 7490681
[TBL] [Abstract][Full Text] [Related]
12. Hepatic drug-metabolizing enzymes in primary and secondary tumors of human liver.
el Mouelhi M; Didolkar MS; Elias EG; Guengerich FP; Kauffman FC
Cancer Res; 1987 Jan; 47(2):460-6. PubMed ID: 3024821
[TBL] [Abstract][Full Text] [Related]
13. Expression of glutathione S-transferases in fetal lung and liver tissue from parental strains and F1 crosses between C57BL/6 and BALB/c F1 mice following in utero exposure to 3-methylcholanthrene.
Xu M; Moore JE; Leone-Kabler S; McCoy TP; Swank A; Nelson GB; Ross JA; Townsend AJ; Miller MS
Biochem Pharmacol; 2006 Jun; 72(1):115-23. PubMed ID: 16678797
[TBL] [Abstract][Full Text] [Related]
14. Cytochrome p450 and glutathione transferase expression in human breast cancer.
El-Rayes BF; Ali S; Heilbrun LK; Lababidi S; Bouwman D; Visscher D; Philip PA
Clin Cancer Res; 2003 May; 9(5):1705-9. PubMed ID: 12738724
[TBL] [Abstract][Full Text] [Related]
15. GST-pi expression correlates with oxidative stress and apoptosis in breast cancer.
Huang J; Tan PH; Tan BK; Bay BH
Oncol Rep; 2004 Oct; 12(4):921-5. PubMed ID: 15375523
[TBL] [Abstract][Full Text] [Related]
16. Elevation of pi class glutathione S-transferase activity in human breast cancer cells by transfection of the GST pi gene and its effect on sensitivity to toxins.
Moscow JA; Townsend AJ; Cowan KH
Mol Pharmacol; 1989 Jul; 36(1):22-8. PubMed ID: 2747627
[TBL] [Abstract][Full Text] [Related]
17. Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human alpha class glutathione S-transferase gene.
Leyland-Jones BR; Townsend AJ; Tu CP; Cowan KH; Goldsmith ME
Cancer Res; 1991 Jan; 51(2):587-94. PubMed ID: 1985777
[TBL] [Abstract][Full Text] [Related]
18. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
[TBL] [Abstract][Full Text] [Related]
19. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
20. Expression of xenobiotic metabolizing enzymes in breast cancer.
Murray GI; Weaver RJ; Paterson PJ; Ewen SW; Melvin WT; Burke MD
J Pathol; 1993 Mar; 169(3):347-53. PubMed ID: 8492228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
